11/14/2024
8:00 PM | Redmile Group, LLC (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
8:42 AM | Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
7:33 AM | Repare Therapeutics (Filer)
| Form 424B5 | |
11/07/2024
6:10 AM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:15 AM | Repare Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
11:15 PM | Repare Therapeutics (Filer)
| Form EFFECT | |
08/07/2024
8:06 AM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/06/2024
3:41 PM | Repare Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/06/2024
3:20 PM | Repare Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/20/2024
3:27 PM | Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2024
3:36 PM | Repare Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Civik Thomas (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Bonita David P (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Kulkarni Samarth (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Molineaux Susan (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Morrison Briggs (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Repare Therapeutics (Issuer)
RHOADS ANN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:06 PM | Repare Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/26/2024
3:14 PM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:27 PM | Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
8:28 PM | Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
8:30 PM | Forte Steve (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
8:31 PM | Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
5:54 PM | Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
5:56 PM | Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
5:57 PM | Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
5:59 PM | Forte Steve (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
11:37 AM | Forte Steve (Reporting)
Repare Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
1:50 PM | Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
6:25 PM | Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:23 PM | Koehler Maria (Reporting)
Repare Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:23 PM | Repare Therapeutics (Subject)
Zinda Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
8:02 PM | Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:04 PM | Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:06 PM | Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:10 AM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:15 AM | Repare Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
8:02 PM | Blue Owl Capital Holdings LP (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
7:54 AM | Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G/A | |
01/29/2024
3:01 PM | ARK Investment Management LLC (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G/A | |
The only candlestick pattern worth a darn (Ad) It’s widely known that 80% of daily market action is driven by Wall Street algorithms…
Now, most people think of the algorithms are “bad”
When in reality, they are neither good nor bad…
They are simply programmed to buy and sell certain stocks over and over again…
But here is the thing…
They are predictable…
They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… |
01/25/2024
1:29 PM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:05 PM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
3:19 PM | Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:52 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Repare Therapeutics (Subject)
| Form SC 13D/A | |
11/17/2023
3:54 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free RPTX Stock Alerts